Evidence map›Paper›PMID 37868543›Full record

ArticleCureus2023

IgA Vasculitis Followed by IgA Nephropathy Without an Identifiable Trigger: The Same Disease or a Spectrum of Related Conditions?

Rebecca Lapides, Juan Crespo-Quezada, Teena Thomas, Felipe Carmona Pires, Gagandeep Chera

Open access · diamondAbstract readCase Reports
In one paragraph

Article in Cureus, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.4field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 2 citations in OpenAlex.

  1. An Unusual Presentation of IgA Vasculitis and IgA Nephropathy: A Case Report.Journal of community hospital internal medicine perspectives · 2025
    Article
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Rebecca LapidesDepartment of Internal Medicine, Robert Larner, M.D. College of Medicine at the University of Vermont, Burlington, USA.
Juan Crespo-QuezadaDepartment of Internal Medicine, Connecticut Institute for Communities, Danbury, USA.
Teena ThomasDepartment of Internal Medicine, Danbury Hospital, Danbury, USA.
Felipe Carmona PiresDepartment of Internal Medicine, Danbury Hospital, Danbury, USA.
Gagandeep CheraDepartment of Internal Medicine, Connecticut Institute for Communities, Danbury, USA.
University of Vermont Medical Center · USUniversity of Vermont · USWestern Connecticut State University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

IgA vasculitis and IgA nephropathy are characterized by IgA deposition in blood vessels and glomerular mesangium, respectively. The former is far more common in the pediatric population, while the latter presents more often in adulthood. A consensus regarding whether these two conditions are manifestations of the same disease that occurs on a spectrum has not yet been reached, and, to our knowledge, no clinical trials to address this question have been conducted. Here, we describe a 27-year-old patient who presented to the emergency department multiple times before being diagnosed with IgA vasculitis with no identifiable trigger and soon after developed IgA nephropathy. This case highlights the importance of ruling out these conditions, especially IgA vasculitis, in adults presenting with a petechial rash, but also the need for studies that investigate whether and how these conditions are related so that patients can be appropriately diagnosed and treated as efficiently as possible.

Indexed as

henoch-schönlein purpura (iga vasculitis)iga mediated vasculitisiga nephropathypalpable purpurapetechial rash

Identifiers

PMID37868543
PMCPMC10589066
OpenAlexW4386881401

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.